title: Rationale for the selection of an aerosol delivery system for gene delivery.
abstract: Genetic therapeutics show great promise toward the treatment of illnesses associated with the lungs; however, current methods of delivery such as jet and ultrasonic nebulization decrease the activity and effectiveness of these treatments. Extremely low transfection rates exhibited by non-complexed plasmid DNA in these nebulizers have been primarily attributed to poor translocation and loss of molecular integrity as a consequence of shear-induced degradation. Current research focusing on methods to increase transfection rates via the pulmonary delivery route has largely concentrated on the incorporation of carbon dioxide in the air stream to increase breath depth as well as the addition of cationic agents that condense DNA into compact, ordered complexes. The purpose of this study was to examine the impact of several classic as well as the latest atomization devices on the structure of non-complexed DNA. Various sizes of plasmid and cosmid DNA were processed through an electrostatic spray, ultrasonic nebulizer, vibrating mesh nebulizer, and jet nebulizer. Results varied dramatically based upon atomization device as well as DNA size. This may explain the inefficiency experienced by genetic therapeutics during pulmonary delivery. More importantly, this suggests that the selection of an atomization device should consider DNA size in order to achieve optimal gene delivery to the lungs.
authors.affiliation: School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado, USA.
authors.forename: Yvonne K
authors.initials: YK
authors.lastname: Lentz
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Anchordoquy
authors.forename: Corinne S
authors.initials: CS
authors.lastname: Lengsfeld
mesh_terms: D000280:Administration, Inhalation; D000336:Aerosols; D004247:DNA / Q000737:chemistry; D018014:Gene Transfer Techniques; D005821:Genetic Techniques; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D008168:Lung / Q000473:pathology; D009330:Nebulizers and Vaporizers; D010316:Particle Size; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D010957:Plasmids / Q000378:metabolism; D055672:Static Electricity; D014162:Transfection
chemical_list: D000336:Aerosols; D004364:Pharmaceutical Preparations; D004247:DNA